| | | | | |
HIO Western Asset High Income Opportunity Fund, Inc. | €3,1650 | +0,00% | €300,98M | €227,22K | |
SORN Soren Acquisition Corp. Class A Ordinary Shares | €8,6667 | +0,00% | €300,41M | €14,64K | |
SSSS SuRo Capital Corp. Common Stock | €11,5440 | +0,23% | €300,27M | €245,64K | |
BCML BayCom Corp Common Stock | €27,4038 | -0,38% | €300,09M | €114,34K | |
PRLD Prelude Therapeutics Incorporated | €3,7622 | -0,12% | €299,99M | €228,55K | |
HPF John Hancock Preferred Income Fund II | €13,8545 | +0,00% | €299,96M | €25,23K | |
GLSI Greenwich LifeSciences, Inc. | €20,6553 | +1,33% | €299,21M | €67,17K | |
FNLC First Bancorp, Inc. (ME) | €26,4883 | +0,00% | €298,67M | €26,72K | |
RM REGIONAL MANAGEMENT CORP | €32,4347 | +0,00% | €298,66M | €26,91K | |
HCMA HCM III Acquisition Corp. Class A Ordinary Share | €8,9501 | -0,15% | €298,53M | €4,79K | |
| €3,5486 | +0,00% | €298,39M | €601,22K | |
CHMG Chemung Financial Corp | €61,7741 | -0,17% | €298,24M | €76,64K | |
DSAC Daedalus Special Acquisition Corp. Class A Ordinary Shares | €8,7626 | +0,00% | €298,08M | €2,88K | |
CURR Currenc Group Inc. Ordinary Shares | €2,6506 | +0,33% | €296,63M | €160,56K | |
UPB Upstream Bio, Inc. Common Stock | €5,4363 | -0,24% | €296,55M | €524,70K | |
